Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4949)
All Articles published online
|
Publishing Process of This Article
|
Dec 21, 2013 (publication date) through Jul 16, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Mangia A, Mottola L, Santoro R. Interleukin 28B polymorphisms as predictor of response in hepatitis C virus genotype 2 and 3 infected patients. World J Gastroenterol 2013; 19(47): 8924-8928 [PMID: 24379617 DOI: 10.3748/wjg.v19.i47.8924] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i47/8924.htm |
| Number | Citing Articles |
| 1 |
Simone Susser, Eva Herrmann, Christian Lange, Nabila Hamdi, Tobias Müller, Thomas Berg, Dany Perner, Stefan Zeuzem, Christoph Sarrazin, Ferruccio Bonino. Predictive Value of Interferon-Lambda Gene Polymorphisms for Treatment Response in Chronic Hepatitis C. PLoS ONE 2014; 9(11): e112592 doi: 10.1371/journal.pone.0112592
|
| 2 |
|
| 3 |
Chia‐Yen Dai, Wan‐Long Chuang, Ming‐Lung Yu. Variants of the inosine triphosphate pyrophosphatase gene and relapse risk following treatment for HCV genotype 2/3. Hepatology 2014; 60(6): 2129 doi: 10.1002/hep.27109
|
| 4 |
Jessica Cusato, Sarah Allegra, Lucio Boglione, Amedeo De Nicolò, Lorena Baietto, Giuseppe Cariti, Giovanni Di Perri, Antonio D'Avolio. Vitamin D Pathway Gene Variants and HCV-2/3 Therapy Outcomes. Antiviral Therapy 2015; 20(3): 335 doi: 10.3851/IMP2853
|
| 5 |
Alessandro Antonelli, Silvia Martina Ferrari, Ilaria Ruffilli, Poupak Fallahi. Cytokines and HCV-related autoimmune disorders. Immunologic Research 2014; 60(2-3): 311 doi: 10.1007/s12026-014-8569-1
|
| 6 |
P Ranjan, GJ Fletcher, M Radhakrishnan, J Sivakumar, PS Premkumar, A Goel, UG Zachariah, P Abraham. Association of interleukin-28B rs12979860 and rs8099917 polymorphisms with sustained viral response in hepatitis C virus genotype 1 and 3 infected patients from the Indian subcontinent. Indian Journal of Medical Microbiology 2016; 34(3): 335 doi: 10.4103/0255-0857.188329
|
| 7 |
L. Nosotti, A. Petrelli, D. Genovese, S. Catone, C. Argentini, S. Vella, A. Rossi, G. Costanzo, A. Fortino, L. Chessa, L. Miglioresi, C. Mirisola. Distribution of IL28B Polymorphism in a Cohort of Italians and Immigrants with HCV Infection: Association with Viraemia, Stage of Fibrosis and Response to Treatment. Journal of Immigrant and Minority Health 2017; 19(4): 876 doi: 10.1007/s10903-016-0444-9
|
| 8 |
Thomas Kuntzen, Sereina Kuhn, Daniela Kuntzen, Burkhardt Seifert, Beat Müllhaupt, Andreas Geier, Golo Ahlenstiel. Influence of Ribavirin Serum Levels on Outcome of Antiviral Treatment and Anemia in Hepatitis C Virus Infection. PLOS ONE 2016; 11(7): e0158512 doi: 10.1371/journal.pone.0158512
|
| 9 |
Bianca Heinrich, John P. Bilello. Antimicrobial Drug Resistance. 2017; : 579 doi: 10.1007/978-3-319-46718-4_39
|
| 10 |
E. Riva, C. Scagnolari, O. Turriziani, G. Antonelli. Hepatitis C virus and interferon type III (interferon-λ3/interleukin-28B and interferon-λ4): genetic basis of susceptibility to infection and response to antiviral treatment. Clinical Microbiology and Infection 2014; 20(12): 1237 doi: 10.1111/1469-0691.12797
|
| 11 |
Valli De Re, Mariangela De Zorzi, Laura Caggiari, Gianfranco Lauletta, Maria Lina Tornesello, Elisa Fognani, Marta Miorin, Vito Racanelli, Luca Quartuccio, Laura Gragnani, Sabino Russi, Fabio Pavone, Michela Ghersetti, Elena Garlatti Costa, Pietro Casarin, Riccardo Bomben, Cesare Mazzaro, Giancarlo Basaglia, Massimiliano Berretta, Emanuela Vaccher, Francesco Izzo, Franco Maria Buonaguro, Salvatore De Vita, Anna Linda Zignego, Paolo De Paoli, Riccardo Dolcetti. HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2. Oncotarget 2016; 7(25): 37487 doi: 10.18632/oncotarget.9303
|
| 12 |
Ching-Chih Hu, Chih-Lang Lin, Liang-Che Chang, Cheng-Hung Chien, Li-Wei Chen, Ching-Jung Liu, Rong-Nan Chien. Interleukin-28B gene non-TT allele strongly predicts treatment failure for genotype 1 infected chronic hepatitis C patients with advanced fibrosis: a case control study. BMC Infectious Diseases 2015; 15(1) doi: 10.1186/s12879-015-0888-x
|
| 13 |
Jacqueline C.M. Paterson, Michael H. Miller, John F. Dillon. Update on the treatment of hepatitis C genotypes 2–6. Current Opinion in Infectious Diseases 2014; 27(6): 540 doi: 10.1097/QCO.0000000000000114
|
| 14 |
Qingxian Cai, Xiaohong Zhang, Chaoshuang Lin, Xiaoqiong Shao, Yujuan Guan, Hong Deng, Min Wei, Mingshou Huang, Zefang Ren, Ling Lu, Yongyu Mei, Min Xu, Jianyun Zhu, Haiyan Shi, Guoli Lin, Ying Liu, Fengyu Hu, Qiumin Luo, Yun Lan, Fengxia Guo, Zhixin Zhao, Zhiliang Gao, Dimitrios Paraskevis. 24 versus 48 Weeks of Peginterferon Plus Ribavirin in Hepatitis C Virus Genotype 6 Chronically Infected Patients with a Rapid Virological Response: A Non-Inferiority Randomized Controlled Trial. PLOS ONE 2015; 10(10): e0140853 doi: 10.1371/journal.pone.0140853
|
| 15 |
Meng Wang, Jian-sheng Li, Yu Ping, Zhi-qin Li, Li-ping Wang, Qian Guo, Zhen Zhang, Dong-li Yue, Fei Wang, Teng-fei Zhang, Mohammad Serajul Islam, Yi Zhang. The host HLA-A*02 allele is associated with the response to pegylated interferon and ribavirin in patients with chronic hepatitis C virus infection. Archives of Virology 2015; 160(4): 1043 doi: 10.1007/s00705-015-2361-y
|
| 16 |
Michael S. Forman, Alexandra Valsamakis.
Manual of
Clinical Microbiology. 2015; : 1599 doi: 10.1128/9781555817381.ch92
|